Myrto Samara

9.2k total citations · 4 hit papers
80 papers, 5.9k citations indexed

About

Myrto Samara is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Myrto Samara has authored 80 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Psychiatry and Mental health, 22 papers in Pharmacology and 15 papers in Clinical Psychology. Recurrent topics in Myrto Samara's work include Schizophrenia research and treatment (49 papers), Treatment of Major Depression (20 papers) and Bipolar Disorder and Treatment (13 papers). Myrto Samara is often cited by papers focused on Schizophrenia research and treatment (49 papers), Treatment of Major Depression (20 papers) and Bipolar Disorder and Treatment (13 papers). Myrto Samara collaborates with scholars based in Germany, Greece and United Kingdom. Myrto Samara's co-authors include Stefan Leucht, John M. Davis, Georgia Salanti, Andrea Cipriani, Stephan Heres, John Geddes, Dimitris Mavridis, Maximilian Huhn, Rolf R. Engel and Loukia M. Spineli and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Cochrane Database of Systematic Reviews.

In The Last Decade

Myrto Samara

70 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

2013 1.8k citations Stefan Leucht, Andrea Cipriani et al. profile →
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

2019 963 citations Maximilian Huhn, Johannes Schneider‐Thoma et al. profile →
Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.

2016 485 citations Stefan Leucht, Myrto Samara et al. Schizophrenia Bulletin profile →
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

2017 350 citations Stefan Leucht, Claudia Leucht et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Myrto Samara Germany	25	4.0k	969	855	763	733	80	5.9k
Antony Loebel United States	41	5.3k 1.3×	1.1k 1.1×	1.1k 1.3×	639 0.8×	829 1.1×	226	6.4k
Robert Lasser United States	33	3.4k 0.8×	1.0k 1.0×	927 1.1×	633 0.8×	1.1k 1.4×	94	4.8k
Larry Alphs United States	36	3.8k 1.0×	1.1k 1.1×	921 1.1×	584 0.8×	937 1.3×	174	5.2k
Bruce J. Kinon United States	47	5.0k 1.3×	1.1k 1.1×	845 1.0×	882 1.2×	789 1.1×	153	7.4k
Philippe Conus Switzerland	52	5.3k 1.3×	2.4k 2.4×	713 0.8×	854 1.1×	1.0k 1.4×	307	8.5k
Robin Emsley South Africa	50	5.2k 1.3×	2.4k 2.5×	746 0.9×	853 1.1×	1.4k 1.9×	281	8.5k
Miquel Bernardo Spain	49	5.5k 1.4×	1.5k 1.6×	994 1.2×	1.7k 2.3×	844 1.2×	406	8.8k
Ruud van Winkel Belgium	48	5.3k 1.3×	2.2k 2.2×	836 1.0×	872 1.1×	740 1.0×	201	9.1k
István Bitter Hungary	34	3.7k 0.9×	975 1.0×	726 0.8×	1.5k 2.0×	481 0.7×	156	5.1k
Alexander L. Miller United States	44	3.7k 0.9×	1.1k 1.1×	719 0.8×	633 0.8×	962 1.3×	145	6.0k

Countries citing papers authored by Myrto Samara

Since Specialization

Citations

This map shows the geographic impact of Myrto Samara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myrto Samara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myrto Samara more than expected).

Fields of papers citing papers by Myrto Samara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myrto Samara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myrto Samara. The network helps show where Myrto Samara may publish in the future.

Co-authorship network of co-authors of Myrto Samara

This figure shows the co-authorship network connecting the top 25 collaborators of Myrto Samara. A scholar is included among the top collaborators of Myrto Samara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myrto Samara. Myrto Samara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lappas, Andreas S., Bartosz Helfer, Spyridon Siafis, et al.. (2025). Examining the safety profile of clozapine versus other antipsychotics: systematic review and meta-analysis. The British Journal of Psychiatry. 1–10.

Samara, Myrto, Andreas S. Lappas, Spyridon Siafis, et al.. (2025). Efficacy and tolerability of pharmacological interventions for schizophrenia non-responsive to prior treatment: a systematic review and network meta-analysis. EClinicalMedicine. 84. 103291–103291. 1 indexed citations

Tsiptsios, Dimitrios, Andreas S. Triantafyllis, Christoph Mueller, et al.. (2025). Molecular Basis of Anxiety: A Comprehensive Review of 2014–2024 Clinical and Preclinical Studies. International Journal of Molecular Sciences. 26(11). 5417–5417.

Lappas, Andreas S., Μαρία Ιωάννου, Myrto Samara, & George N. Christodoulou. (2025). Autophagy in Schizophrenia: A Continuum From Developmental Vulnerability to Progressive Neuronal Stress? A Scoping Review. Schizophrenia Bulletin. 52(2).

Lappas, Andreas S., et al.. (2024). Pharmacotherapy for sleep disturbances in post-traumatic stress disorder (PTSD): A network meta-analysis. Sleep Medicine. 119. 467–479. 2 indexed citations

Lappas, Andreas S., et al.. (2024). Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis. European Neuropsychopharmacology. 84. 5–15. 3 indexed citations

Samara, Myrto, Dimitra Rafailia Bakaloudi, Andreas S. Lappas, et al.. (2023). Remote vs Face-to-face Interventions for Bulimia Nervosa and Binge-eating Disorder: a Systematic Review and Meta-analysis. Journal of Technology in Behavioral Science. 9(3). 452–462. 3 indexed citations

Lappas, Andreas S., et al.. (2023). Antimanic Efficacy, Tolerability, and Acceptability of Clonazepam: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12(18). 5801–5801. 2 indexed citations

Lappas, Andreas S., Dimitra Rafailia Bakaloudi, George N. Christodoulou, et al.. (2023). Pharmacotherapy compared to placebo for people with Bulimia Nervosa: A systematic review and meta-analysis. Psychiatry Research. 327. 115357–115357. 10 indexed citations

10.

Samara, Myrto, Maximilian Huhn, Virginia Chiocchia, et al.. (2020). Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: a systematic review and network meta‐analysis. Acta Psychiatrica Scandinavica. 142(1). 6–17. 39 indexed citations

11.

Samara, Myrto, et al.. (2020). The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis. Psychiatry Research. 291. 113246–113246. 15 indexed citations

12.

Kalopitas, Georgios, Christina Antza, Ioannis Doundoulakis, et al.. (2020). Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis. Nutrition. 83. 111092–111092. 54 indexed citations

13.

Antza, Christina, Dimitra Rafailia Bakaloudi, Ioannis Doundoulakis, et al.. (2020). Systematic review with meta‐analysis: The effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 36(2). 311–319. 56 indexed citations

14.

Antza, Christina, Dimitra Rafailia Bakaloudi, Ioannis Doundoulakis, et al.. (2020). The effect of vitamin e supplementation in liver enzymes, histology and metabolic biomarkers in adult patients with non-alcoholic fatty liver disease (NAFLD). a systematic review and meta-analysis. Clinical Nutrition ESPEN. 40. 458–459.

15.

Kalopitas, Georgios, Christina Antza, Ioannis Doundoulakis, et al.. (2020). The impact of silymarin in patients with non-alcoholic fatty liver disease: A systematic review and meta-Analysis. Clinical Nutrition ESPEN. 40. 515–515. 1 indexed citations

16.

Efthimiou, Orestis, Dimitris Mavridis, Thomas P. A. Debray, et al.. (2017). Combining randomized and non‐randomized evidence in network meta‐analysis. Statistics in Medicine. 36(8). 1210–1226. 130 indexed citations

17.

Leucht, Stefan, Claudia Leucht, Maximilian Huhn, et al.. (2017). Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry. 174(10). 927–942. 350 indexed citations breakdown →

18.

Leucht, Stefan, Myrto Samara, Stephan Heres, & John M. Davis. (2016). Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.. Schizophrenia Bulletin. 42(suppl 1). S90–S94. 485 indexed citations breakdown →

19.

Samara, Myrto, et al.. (2014). Chlorpromazine versus every other antipsychotic for schizophrenia: A systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs. European Neuropsychopharmacology. 24(7). 1046–1055. 24 indexed citations

20.

Fountoulakis, Konstantinos Ν., et al.. (2011). Tardive Tourette-like syndrome. International Clinical Psychopharmacology. 26(5). 237–242. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact